Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Horizon Beefs Up (While Burning Through Cash)

Today, health-care analysts Brenton Flynn and David Williamson discuss Horizon Pharmaceutical (NASDAQ: HZNP  ) s and the recent completion of its salesforce rollout for for Duexis. The company expects to reach about 50% of necessary doctors, and Brenton excepts a commiserate acceleration in sales.

Duexis is a crucial drug for the company, but it's burning through cash at the moment and faces generic competition, so this salesforce announcement is more important than just increasing sales: It has huge implications for the company's future viability.

When it comes to do-or-die business, the biotech industry takes the cake. Arena Pharmaceuticals is one recent success story in the industry after gaining FDA approval for its innovative obesity drug. While the future looks bright for Arena, there are still plenty of obstacles ahead. In our brand-new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.

Brenton Flynn, Dave Williamson, and The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Covidien. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 02, 2012, at 5:20 AM, txwonk wrote:

    Latest update on news is that HZNP raised 81 million via additional sale of stock. Exactly how are they "burning through cash"? Then, they also got 2 additional patents on Duexis---so please explain exactly how any "generics" are going to be competing with this anytime soon. Then the CEO apparently bought $2 million of company stock--and he did so on the same day they received patent approvals. Sure, it may take a little time to get doctors to start prescribing it, but at least with Covidien lined up as a distributor, things are all set to roll. Anyone ignoring all those bits of news must clearly have another agenda.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2039354, ~/Articles/ArticleHandler.aspx, 10/26/2016 1:34:37 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,203.27 34.00 0.19%
S&P 500 2,139.98 -3.18 -0.15%
NASD 5,257.05 -26.35 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
COV.DL $0.00 Down +0.00 +0.00%
Covidien CAPS Rating: *****
HZNP $18.28 Down -0.04 -0.19%
Horizon Pharma CAPS Rating: **